Legislators in two states have pushed back against efforts to restrict Prescription Drug Affordability Boards, the controversial panels designed to function as rate-setting authorities and impose limits on prescription drug costs.
Virginia Rejects Governor’s Delay on Drug Affordability Board
In Virginia, the General Assembly unanimously rejected a proposal by Governor Abigail Spanberger, a Democrat, to delay a key provision of two bills that would establish a state board and authorize it to set price caps mirroring the negotiated rates paid by Medicare. Spanberger now faces a decision: either accept the legislation as originally intended or veto it.
Colorado Shelves Bill Exempting Orphan Drugs from Pricing Caps
In Colorado, the House Health and Human Services Committee postponed consideration of a bill that would have exempted orphan drugs—used to treat rare diseases—from potential pricing caps imposed by the state board. By deferring action until the end of the legislative session, the bill has effectively been shelved.